Impact of CYP2E1 genotype in renal cell and urothelial cancer patients
Authors:
- 30 September 1998
- journal article
- research article
- Published by Elsevier in Experimental and Toxicologic Pathology
- Vol. 50 (4-6) , 425-431
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- A cytochrome P4502E1 genetic polymorphism and tobacco smoking in breast cancerMolecular Carcinogenesis, 1996
- P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclaturePharmacogenetics, 1996
- Role of ethanol-inducible cytochrome p-450 2E1 in the development of hepatocellular carcinoma by the chemical carcinogen, N-nitrosodimethylamineHepatology, 1993
- Genetic Risk and Carcinogen Exposure: a Common Inherited Defect of the Carcinogen-Metabolism Gene Glutathione S-Transferase M1 (GSTM1) That Increases Susceptibility to Bladder CancerJNCI: Journal of the National Cancer Institute, 1993
- The human CYP2E1 gene and lung cancer: DraI and RsaI restriction fragment length polymorphisms in a Finish study populationCarcinogenesis, 1993
- Association between Restriction Fragment Length Polymorphism of the Human Cytochrome P450IIE1 Gene and Susceptibility to Lung CancerJapanese Journal of Cancer Research, 1991
- Cytochrome P450IIe1: Roles in Nitrosamine Metabolism and Mechanisms of RegulationDrug Metabolism Reviews, 1990
- Carbon tetrachloride‐induced lipid peroxidation dependent on an ethanol‐inducible form of rabbit liver microsomal cytochrome P‐450FEBS Letters, 1985
- The nature of microsomal N-nitrosodimethylamine demethylase and its role in carcinogen activationCarcinogenesis, 1985
- Toxicology: Nitrosamines and human cancer: proof of an association?Nature, 1983